MPC Therapeutics

About:

MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.

Website: https://www.mpc-therapeutics.com/

Top Investors: Innosuisse, FONGIT Innovation Fund, Plutus Investment Group, Eclosion SA, KICK Ventures

Description:

MPC Therapeutics is a biotechnology company. For patients with cancer and degenerative disorders, the company is presently concentrating on creating life-altering medications. They develop a class of compounds with the ability to modify mitochondrial processes in order to alter the conductivity of the cell and prevent the growth of diseases by using their medicinal chemistry and mitochondrial biology.